Skip to main content
Premium Trial:

Request an Annual Quote

Alan Edrick, Charles Best, Patrick Balthrop, Thomas Erickson, and Mark Chandler


BioSource International has appointed Alan Edrick executive vice president and chief financial officer.

Edrick replaces Charles Best, who resigned from the company earlier this month.

Edrick has more than 15 years of financial management and public accounting experience, BioSource said. Most recently, he served as senior vice president and chief financial officer at North American Scientific, a medical device and specialty pharmaceutical company. Prior to this, he worked for several years at PriceWaterhouse in various positions.

He holds a BA degree from UCLA and an MBA from UCLA's Anderson School of Business.

Luminex has named Patrick Balthrop as CEO and president, filling the two top spots that were being overseen by Thomas Erickson, a professional interim president.

Balthrop comes to Luminex from Fisher Scientific International, where he was president of the Fisher Healthcare division since 2002. Previously, he was head of worldwide commercial diagnostics operations at Abbott Diagnostics.

Balthrop was appointed 20 months after Luminex's CEO Mark Chandler left the company to head a spin-off based on the company's Rules-Based Medicine project. Luminex expects Balthorp to become a company director.

Erickson will remain as a company director and chairman of the executive committee, subject to his election to the board during the company's annual meeting of stockholders May 20.

To sweeten the deal for Balthorp, Luminex gave him a restricted stock grant for 200,000 shares of common stock at $9.36 per share, and a contractual option grant to buy 500,000 shares of common stock.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.